1
Richard L Dunn, James P English, Donald R Cowsar, David P Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Needle & Rosenberg, July 3, 1990: US04938763 (507 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


2
Richard L Dunn, James P English, Donald R Cowsar, David P Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Atrix Laboratories, Merchant Gould Smith Edell Welter & Schmidt, January 11, 1994: US05278201 (255 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


3
Richard L Dunn, James P English, Donald R Cowsar, David D Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Atrix Laboratories, Merchant Gould Smith Smith Edell & Welter, January 11, 1994: US05278202 (218 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


4
Richard L Dunn, James P English, Donald R Cowsar, David P Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Atrix Laboratories, Merchant & Gould P C, November 23, 1999: US05990194 (123 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


5
Richard L Dunn, James P English, Donald R Cowsar, David D Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Atrix Laboratories, Merchant Gould Smith Edell Welter & Schmidt, April 14, 1998: US05739176 (123 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


6
Richard L Dunn, James P English, Donald R Cowsar, David P Vanderbilt: Biodegradable in-situ forming implants and methods of producing the same. Atrix Laboratories Incorporated, Merchant Gould Smith Edell Welter & Schmidt, March 31, 1998: US05733950 (94 worldwide citation)

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


7
Dunn Richard L, English James P, Cowsar Donald R, Vanderbilt David P: Implants biodegradables formes in situ et methodes pour les obtenir, Biodegradable in-situ forming implants and methods of producing the same. Southern Research Institute, Atrix Laboratories, FINLAYSON & SINGLEHURST, August 3, 1999: CA1340694

A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a ...


8
COMPUTER IMPLEMENTED PLANNING AND PROVIDING OF MASS CUSTOMIZED BONE STRUCTURE. November 30, 2017: US20170344720-A1

A computer-implemented method, a system and a computer program is disclosed, which comprise virtual planning of a medical procedure of a patient. The medical procedure comprises providing a patient configured bone structure in a body portion of the patient. Based on an input of a final result of the ...


9
INJECTION SOLUTION COMPRISING A NON-NUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR AND POLY(LACTIDE-CO-GLYCOLIDE). Evonik Roehm, November 8, 2018: US20180318211-A1

An injection solution can be used in a pharmaceutical dosage formulation. The injection solution includes an organic solvent, a copolymer, which is a poly(lactide-co-glycolide) dissolved in the organic solvent, and a pharmaceutical active ingredient, which is a non-nucleoside inhibitor of the HIV re ...